Principal Securities, Inc. Roivant Sciences Ltd. Transaction History
Principal Securities, Inc.
- $5.32 Trillion
- Q2 2025
A detailed history of Principal Securities, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Principal Securities, Inc. holds 203 shares of ROIV stock, worth $3,256. This represents 0.0% of its overall portfolio holdings.
Number of Shares
203
Previous 225
9.78%
Holding current value
$3,256
Previous $2.66 Million
14.05%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
362Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$962 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$717 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$631 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$567 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$549 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $11.3B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...